For three months, the Federal Trade Commission had been holding hearings to find out whether the federal fair trade laws had been violated by five big manufacturers of anti-cold drugs.-Last week in Washington, FTC abruptly announced that the hearings had been called off. Reason: the companies, which had ballyhooed across-the-drug-counter sales of anti-his-taminics into a potential $100-million-a-year business, had signed agreements to mend their advertising ways.
FTC, watchdog of U.S. business trade and advertising practices, announced that the companies had agreed to stop "misrepresentations" in their advertising. Said FTC sternly: "Unjustified claims for...
To continue reading:
or
Log-In
